comparemela.com

Latest Breaking News On - Heart failure therapeutics - Page 1 : comparemela.com

BioCardia Reports First Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for th.

United statesPeter altmanBiocardia incMaryland stem cell research fundEuropean society of cardiology heart failure congressMedicaid servicesExchange commissionDevice agencyCompany annual report on formExchange commission onCell therapyIschemic heart failureFailure trialHeart failure therapeuticsTherapy heart failureChronic myocardial ischemia

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanEuropean society of cardiology heart failure congressBiocardia incExchange commission onMedicaid servicesExchange commissionMaryland stem cell research fundDevice agencyBiocardia reports first quarterFinancial resultsCell therapyIschemic heart failureFailure trialHeart failure therapeuticsTherapy heart failure

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBrian mullenChris giordanoJohn frauncesJaved butlerDaniel burkhoffSanjiv shahNasdaq stock marketResearch for the bluhm cardiovascular instituteOrion corporationLifesci advisorsTenax therapeutics incMd northwestern universityTrademark officeCardiovascular research foundation technologyGlobal development

BioCardia, Inc (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript

BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.

United statesDavid mcclungPeter altmanBrent pearsonJoe smithMiranda petoLargest airport companiesSam clubDevice agencyBiocardia incCall transcript marchEnd financial resultsBusiness update conferenceBiocardia investorChief executive officerChief financial

The Congestion Index Improves Heart Failure Event Prediction Relative to the Weight Rule

A novel congestion index has higher sensitivity compared with standard weight-based rules for predicting heart failure events.

United statesDuke healthDrug administrationHeart failure therapeuticsBodyport cardiac scale

vimarsana © 2020. All Rights Reserved.